QQQ   423.29 (-0.60%)
AAPL   166.91 (-0.65%)
MSFT   405.39 (-1.57%)
META   501.50 (+1.48%)
GOOGL   156.22 (+0.48%)
AMZN   179.00 (-1.26%)
TSLA   150.48 (-3.20%)
NVDA   844.72 (+0.52%)
AMD   154.17 (+0.10%)
NIO   4.02 (+2.81%)
BABA   68.88 (+0.09%)
T   16.23 (+0.68%)
F   12.01 (-0.25%)
MU   112.61 (-3.20%)
GE   153.90 (-1.14%)
CGC   8.12 (+25.12%)
DIS   112.83 (-0.10%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.24 (-0.33%)
QQQ   423.29 (-0.60%)
AAPL   166.91 (-0.65%)
MSFT   405.39 (-1.57%)
META   501.50 (+1.48%)
GOOGL   156.22 (+0.48%)
AMZN   179.00 (-1.26%)
TSLA   150.48 (-3.20%)
NVDA   844.72 (+0.52%)
AMD   154.17 (+0.10%)
NIO   4.02 (+2.81%)
BABA   68.88 (+0.09%)
T   16.23 (+0.68%)
F   12.01 (-0.25%)
MU   112.61 (-3.20%)
GE   153.90 (-1.14%)
CGC   8.12 (+25.12%)
DIS   112.83 (-0.10%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.24 (-0.33%)
QQQ   423.29 (-0.60%)
AAPL   166.91 (-0.65%)
MSFT   405.39 (-1.57%)
META   501.50 (+1.48%)
GOOGL   156.22 (+0.48%)
AMZN   179.00 (-1.26%)
TSLA   150.48 (-3.20%)
NVDA   844.72 (+0.52%)
AMD   154.17 (+0.10%)
NIO   4.02 (+2.81%)
BABA   68.88 (+0.09%)
T   16.23 (+0.68%)
F   12.01 (-0.25%)
MU   112.61 (-3.20%)
GE   153.90 (-1.14%)
CGC   8.12 (+25.12%)
DIS   112.83 (-0.10%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.24 (-0.33%)
QQQ   423.29 (-0.60%)
AAPL   166.91 (-0.65%)
MSFT   405.39 (-1.57%)
META   501.50 (+1.48%)
GOOGL   156.22 (+0.48%)
AMZN   179.00 (-1.26%)
TSLA   150.48 (-3.20%)
NVDA   844.72 (+0.52%)
AMD   154.17 (+0.10%)
NIO   4.02 (+2.81%)
BABA   68.88 (+0.09%)
T   16.23 (+0.68%)
F   12.01 (-0.25%)
MU   112.61 (-3.20%)
GE   153.90 (-1.14%)
CGC   8.12 (+25.12%)
DIS   112.83 (-0.10%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.24 (-0.33%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Boston Scientific Co. stock logo
BSX
Boston Scientific
$67.35
-0.9%
$67.17
$48.35
$69.21
$98.81B0.786.33 million shs3.80 million shs
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
$0.40
$0.00
$0.27
$0.55
$144.21M1.02580,077 shsN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
$53.20
$0.00
$44.11
$60.50
$21.28MN/A3,929 shs5,990 shs
Pentair plc stock logo
PNR
Pentair
$78.45
-0.6%
$79.86
$51.38
$85.81
$13.02B1.21.60 million shs558,326 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Boston Scientific Co. stock logo
BSX
Boston Scientific
-0.22%-1.01%+1.07%+11.33%+31.68%
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
0.00%0.00%0.00%0.00%0.00%
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
0.00%0.00%0.00%0.00%+0.00%
Pentair plc stock logo
PNR
Pentair
-1.10%-4.00%-1.85%+11.98%+49.68%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Boston Scientific Co. stock logo
BSX
Boston Scientific
4.3992 of 5 stars
2.53.00.04.23.12.52.5
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/AN/AN/AN/AN/AN/AN/AN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Pentair plc stock logo
PNR
Pentair
4.662 of 5 stars
3.43.03.33.02.41.71.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Boston Scientific Co. stock logo
BSX
Boston Scientific
3.00
Buy$68.501.71% Upside
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/AN/AN/AN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
0.00
N/AN/AN/A
Pentair plc stock logo
PNR
Pentair
2.75
Moderate Buy$87.3311.32% Upside

Current Analyst Ratings

Latest PNR, BSX, PAF, and GSV Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$70.00 ➝ $78.00
4/15/2024
Pentair plc stock logo
PNR
Pentair
Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$100.00
4/8/2024
Pentair plc stock logo
PNR
Pentair
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$85.00 ➝ $101.00
4/4/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$68.00 ➝ $72.00
4/3/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$71.00 ➝ $79.00
4/3/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$69.00 ➝ $80.00
4/2/2024
Pentair plc stock logo
PNR
Pentair
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$90.00 ➝ $92.00
3/22/2024
Pentair plc stock logo
PNR
Pentair
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$91.00
3/12/2024
Pentair plc stock logo
PNR
Pentair
BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$86.00
3/7/2024
Boston Scientific Co. stock logo
BSX
Boston Scientific
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$65.00 ➝ $77.00
3/7/2024
Pentair plc stock logo
PNR
Pentair
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$82.00 ➝ $88.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Boston Scientific Co. stock logo
BSX
Boston Scientific
$14.24B6.94$2.87 per share23.47$13.33 per share5.05
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/AN/AN/AN/A$0.63 per shareN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/AN/AN/AN/AN/A
Pentair plc stock logo
PNR
Pentair
$4.10B3.17$4.38 per share17.91$19.46 per share4.03

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Boston Scientific Co. stock logo
BSX
Boston Scientific
$1.59B$1.0762.9426.522.3911.19%15.99%8.87%4/24/2024 (Confirmed)
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
-$8.74M-$0.03N/AN/AN/AN/A-3.87%-3.78%N/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Pentair plc stock logo
PNR
Pentair
$622.70M$3.7520.9216.551.5215.17%20.80%9.55%4/23/2024 (Confirmed)

Latest PNR, BSX, PAF, and GSV Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2024N/A
Boston Scientific Co. stock logo
BSX
Boston Scientific
$0.51N/A-$0.51N/AN/AN/A  
4/23/2024N/A
Pentair plc stock logo
PNR
Pentair
$0.90N/A-$0.90N/AN/AN/A  
1/31/2024Q4 23
Boston Scientific Co. stock logo
BSX
Boston Scientific
$0.51$0.55+$0.04$0.76$3.59 billion$3.73 billion    
1/30/2024Q4 2023
Pentair plc stock logo
PNR
Pentair
$0.86$0.87+$0.01$0.49$975.36 million$984.60 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Boston Scientific Co. stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/AN/AN/AN/AN/A
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
$2.113.97%N/AN/AN/A
Pentair plc stock logo
PNR
Pentair
$0.921.17%+5.01%24.53%6 Years

Latest PNR, BSX, PAF, and GSV Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/19/2024
Pentair plc stock logo
PNR
Pentair
quarterly$0.231.23%4/18/20244/19/20245/3/2024
2/19/2024
Pentair plc stock logo
PNR
Pentair
quarterly$0.231.23%4/19/20245/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Boston Scientific Co. stock logo
BSX
Boston Scientific
0.44
1.32
0.82
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
N/A
21.71
21.71
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/AN/AN/A
Pentair plc stock logo
PNR
Pentair
0.62
1.65
0.94

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Boston Scientific Co. stock logo
BSX
Boston Scientific
89.07%
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
31.79%
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/A
Pentair plc stock logo
PNR
Pentair
92.37%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Boston Scientific Co. stock logo
BSX
Boston Scientific
48,0001.47 billion1.46 billionOptionable
Gold Standard Ventures Corp stock logo
GSV
Gold Standard Ventures
20358.74 millionN/ANot Optionable
PAF
Invesco FTSE RAFI Asia Pac ex-Jpn ETF
N/A400,000N/ANot Optionable
Pentair plc stock logo
PNR
Pentair
10,500166.02 million164.19 millionOptionable

PNR, BSX, PAF, and GSV Headlines

SourceHeadline
Making Better Essential: Pentair Releases 2023 Corporate Responsibility Report Featuring Its Progress in Advancing SustainabilityMaking Better Essential: Pentair Releases 2023 Corporate Responsibility Report Featuring Its Progress in Advancing Sustainability
businesswire.com - April 18 at 6:55 AM
Zacks Research Comments on Pentair plcs Q2 2024 Earnings (NYSE:PNR)Zacks Research Comments on Pentair plc's Q2 2024 Earnings (NYSE:PNR)
marketbeat.com - April 18 at 5:59 AM
Pentair plc to Post Q1 2024 Earnings of $0.89 Per Share, Zacks Research Forecasts (NYSE:PNR)Pentair plc to Post Q1 2024 Earnings of $0.89 Per Share, Zacks Research Forecasts (NYSE:PNR)
americanbankingnews.com - April 18 at 1:28 AM
Zacks Research Analysts Cut Earnings Estimates for Pentair plc (NYSE:PNR)Zacks Research Analysts Cut Earnings Estimates for Pentair plc (NYSE:PNR)
marketbeat.com - April 17 at 4:47 PM
Pentair (PNR) to Report Q1 Earnings: Whats in the Cards?Pentair (PNR) to Report Q1 Earnings: What's in the Cards?
finance.yahoo.com - April 17 at 2:48 PM
Zurcher Kantonalbank Zurich Cantonalbank Increases Stake in Pentair plc (NYSE:PNR)Zurcher Kantonalbank Zurich Cantonalbank Increases Stake in Pentair plc (NYSE:PNR)
marketbeat.com - April 17 at 9:41 AM
Earnings Preview: Pentair plc (PNR) Q1 Earnings Expected to DeclineEarnings Preview: Pentair plc (PNR) Q1 Earnings Expected to Decline
zacks.com - April 16 at 11:06 AM
Dakota Wealth Management Has $4.84 Million Holdings in Pentair plc (NYSE:PNR)Dakota Wealth Management Has $4.84 Million Holdings in Pentair plc (NYSE:PNR)
marketbeat.com - April 16 at 8:47 AM
Pentair (NYSE:PNR) Upgraded to "Buy" by Northcoast ResearchPentair (NYSE:PNR) Upgraded to "Buy" by Northcoast Research
americanbankingnews.com - April 16 at 4:14 AM
Pentair (PNR) Set to Announce Earnings on TuesdayPentair (PNR) Set to Announce Earnings on Tuesday
americanbankingnews.com - April 16 at 2:36 AM
Northcoast Research Upgrades Pentair (PNR)Northcoast Research Upgrades Pentair (PNR)
msn.com - April 15 at 10:38 PM
Analyst Scoreboard: 14 Ratings For PentairAnalyst Scoreboard: 14 Ratings For Pentair
markets.businessinsider.com - April 15 at 12:36 PM
Vontobel Holding Ltd. Sells 56,100 Shares of Pentair plc (NYSE:PNR)Vontobel Holding Ltd. Sells 56,100 Shares of Pentair plc (NYSE:PNR)
marketbeat.com - April 15 at 9:16 AM
Pentair (NYSE:PNR) Lifted to Buy at Northcoast ResearchPentair (NYSE:PNR) Lifted to Buy at Northcoast Research
marketbeat.com - April 15 at 8:29 AM
Pentair plc (NYSE:PNR) Shares Acquired by Impax Asset Management Group plcPentair plc (NYSE:PNR) Shares Acquired by Impax Asset Management Group plc
marketbeat.com - April 9 at 6:31 PM
Pentair to Release First Quarter 2024 Earnings and Host Investor Conference Call on April 23Pentair to Release First Quarter 2024 Earnings and Host Investor Conference Call on April 23
businesswire.com - April 9 at 6:55 AM
Pentair (NYSE:PNR) PT Raised to $101.00Pentair (NYSE:PNR) PT Raised to $101.00
americanbankingnews.com - April 9 at 4:16 AM
Pinnbrook Capital Management LP Purchases 47,140 Shares of Pentair plc (NYSE:PNR)Pinnbrook Capital Management LP Purchases 47,140 Shares of Pentair plc (NYSE:PNR)
marketbeat.com - April 8 at 10:15 PM
Pentair (NYSE:PNR) PT Raised to $101.00 at CitigroupPentair (NYSE:PNR) PT Raised to $101.00 at Citigroup
marketbeat.com - April 8 at 7:30 PM
Is Now An Opportune Moment To Examine Pentair plc (NYSE:PNR)?Is Now An Opportune Moment To Examine Pentair plc (NYSE:PNR)?
finance.yahoo.com - April 6 at 12:48 PM
Heres Why Pentair plc (PNR) is a Great Momentum Stock to BuyHere's Why Pentair plc (PNR) is a Great Momentum Stock to Buy
zacks.com - April 4 at 1:02 PM
Pentair (NYSE:PNR) Given New $92.00 Price Target at BarclaysPentair (NYSE:PNR) Given New $92.00 Price Target at Barclays
marketbeat.com - April 2 at 3:49 PM
Pentair plc (NYSE:PNR) Shares Sold by Pacer Advisors Inc.Pentair plc (NYSE:PNR) Shares Sold by Pacer Advisors Inc.
marketbeat.com - April 2 at 4:38 AM
The Middleby Corporation: Continued Growth And Cheap Stock Should Lead The Way HigherThe Middleby Corporation: Continued Growth And Cheap Stock Should Lead The Way Higher
seekingalpha.com - April 1 at 1:33 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Boston Scientific logo

Boston Scientific

NYSE:BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Gold Standard Ventures logo

Gold Standard Ventures

NYSEAMERICAN:GSV
Gold Standard Ventures Corp., an exploration stage company, engages in the development of district-scale and other gold-bearing mineral resource properties in Nevada, the United States. Its flagship property is the Railroad-Pinion project covering an area of approximately 53,570 acres located in the Elko County, Nevada. The company was incorporated in 2004 and is headquartered in Vancouver, Canada. As of August 12, 2022, Gold Standard Ventures Corp operates as a subsidiary of Orla Mining Ltd.

Invesco FTSE RAFI Asia Pac ex-Jpn ETF

NYSEARCA:PAF
PowerShares FTSE RAFI Asia Pacific ex-Japan Portfolio (the Fund) is based on the FTSE RAFI Developed Asia Pacific ex Japan Index (Index). The Fund will normally invest at least 90% of its total assets in securities that comprise the Index and American Depositary Receipts (ADRs) based on the securities in the Index. The Index is designed to track the performance of the largest equities of companies domiciled in the Asia Pacific region (excluding Japan), selected based on the four fundamental measures of firm size: book value, income, sales and dividends. The 1000 equities with the highest fundamental strength are weighted according to their fundamental scores. The fundamentally weighted portfolio is rebalanced and reconstituted annually. The Fund invests in consumer discretionary, consumer staples, energy, financials, health care, industrials, information technology and telecommunicaiton services sectors. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.
Pentair logo

Pentair

NYSE:PNR
Pentair plc provides various water solutions in the United States, Western Europe, China, Eastern Europe, Latin America, the Middle East, Southeast Asia, Australia, Canada, and Japan. The company operates through three segments: Flow, Water Solutions, and Pool. The Flow segment designs, manufactures, and sells fluid treatment and pump products and systems, including pressure vessels, gas recovery solutions, membrane bioreactors, wastewater reuse systems and advanced membrane filtration, separation systems, water disposal pumps, water supply pumps, fluid transfer pumps, turbine pumps, solid handling pumps, and agricultural spray nozzles for fluid delivery, ion exchange, desalination, food and beverage, separation technologies in the oil and gas industry, residential and municipal wells, water treatment, wastewater solids handling, pressure boosting, circulation and transfer, fire suppression, flood control, agricultural irrigation, and crop spray in residential, commercial, and industrial markets. The Water Solutions segment provides commercial and residential water treatment products and systems, including pressure tanks, control valves, activated carbon products, commercial ice machines, conventional filtration products, and point-of-entry and point-of-use water treatment systems, as well as installation and preventative services for use in residential whole home water filtration, drinking water filtration, and water softening solutions, as well as commercial total water management and filtration in foodservice operations. The Pool segment provides residential and commercial pool equipment and accessories comprising pumps, filters, heaters, lights, automatic controls, automatic cleaners, maintenance equipment, and pool accessories for applications in residential and commercial pool maintenance, pool repair, renovation, service, and construction and aquaculture solutions. Pentair plc was founded in 1966 and is headquartered in London, the United Kingdom.